On May 20, 2026 C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, reported that C4T management will participate in the upcoming conferences.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO (Free ASCO Whitepaper) & EHA (Free EHA Whitepaper)

Management will participate in a virtual fireside chat on May 26, 2026, at 2:30 pm ET.

2026 Jefferies Global Healthcare Conference

Management will participate in a fireside chat on June 3, 2026, at 8:45 am ET, taking place in New York, New York.

Goldman Sachs 47th Annual Global Healthcare Conference

Management will participate in 1×1 meetings on June 10, 2026, taking place in Miami, FL.

The live webcasts will be available on the Investors section of the company’s website at www.c4therapeutics.com. Archived replays of the webcasts will be available for approximately 90 days following the events.

(Press release, C4 Therapeutics, MAY 20, 2026, View Source [SID1234665891])